Scarica l'app Stockscreener
2.9799
2.40%
0.0699
Precedente Chiudi:
$2.91
Aprire:
$2.84
Volume 24 ore:
25,519
Relative Volume:
0.29
Capitalizzazione di mercato:
$13.13M
Reddito:
$1.44M
Utile/perdita netta:
$-11.90M
Rapporto P/E:
-0.623
EPS:
-4.783
Flusso di cassa netto:
$-13.71M
1 W Prestazione:
-3.56%
1M Prestazione:
-6.59%
6M Prestazione:
+18.72%
1 anno Prestazione:
-63.62%
Intervallo 1D:
$2.84
$3.01
Intervallo di 1 settimana:
$2.84
$3.165
Portata 52W:
$2.07
$12.50
Seastar Medical Holding Corp Stock (ICU) Company Profile
Nome
Seastar Medical Holding Corp
Settore
Industria
Telefono
844-427-8100
Indirizzo
3513 BRIGHTON BLVD, DENVER
Compare ICU vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ICU
Seastar Medical Holding Corp
|
2.9799 | 14.72M | 1.44M | -11.90M | -13.71M | -4.783 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Seastar Medical Holding Corp Borsa (ICU) Ultime notizie
ICU: Continued Revenue Growth for QUELIMMUNE - Smartkarma
ICU: Continued Revenue Growth for QUELIMMUNE® - Yahoo Finance
SeaStar Medical (ICU) Q2 2026 Earnings: Loss Narrows More Than Expected, No Revenue Still ReportedPost-Announcement Reaction - vinanet.vn
SeaStar Medical Holding earnings missed by $0.04, revenue fell short of estimates - Investing.com Canada
SeaStar Medical secures ICD-10-PCS codes for SCD therapy - scanx.trade
SeaStar Medical Q2 Results: Revenue up 82% YoY to $0.6 million - scanx.trade
Earnings call transcript: SeaStar Medical misses Q2 2026 forecasts as stock falls - Investing.com
SeaStar Medical Holding Corp reports results for the quarter ended June 30Earnings Summary - TradingView
SeaStar Medical (ICU) grows QUELIMMUNE sales but warns on going concern - stocktitan.net
SeaStar Medical Holding Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
SEASTAR MEDICAL HOLDING ($ICU) Releases Q2 2026 Earnings - Quiver Quantitative
SeaStar Medical Adds 3 Customers From Children's Hospitals for Its Therapy - Stock Titan
SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates - Yahoo Finance
SeaStar Medical Holding Corp (ICU) Q2 2026 Earnings Report Previ - GuruFocus
SeaStar Medical Holding Corp expected to post a loss of 97 cents a shareEarnings Preview - TradingView
SeaStar Medical Holding Corp (ICU) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
SeaStar Medical sets Aug. 12 webcast on results and progress - Stock Titan
SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026 - Yahoo Finance
SeaStar Medical Holding Corp - TradingKey
SeaStar Medical Holding Corp (ICU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
ICU|SeaStar Medical Holding Corp|Price:3.750|Chg%:+0.010 - TradingKey
ICU|SeaStar Medical Holding Corp|Price:3.280|Chg%:+0.230 - TradingKey
SeaStar Medical Holding Corp (ICU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SeaStar Medical Holding Corp (ICU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SeaStar Medical Holding Corp (ICU) Valuation: PE, PB & Fair Value Analysis - TradingKey
SeaStar Medical Holding Corp (ICU) Institutional Confidence - TradingKey
SeaStar Medical Holding Corp (ICU) Income Statement - TradingKey
SeaStar Medical Holding Corp (ICU) Cash Flow - TradingKey
SeaStar Medical Holding Corp (ICU) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
SeaStar Medical sponsors pediatric kidney injury summit By Investing.com - Investing.com Canada
SeaStar Medical sponsors pediatric kidney injury summit - Investing.com
SeaStar Medical: More Than 50% of Children With Severe Kidney Injury Die - Stock Titan
ICU Q1 2026 Earnings: Narrower Loss Yet Misses Street Estimates, Stock RisesNet Income Trends - vinanet.vn
Kurin, Inc. Extends Record Performance with Two Consecutive Quarters of Record Revenues Driven by Commercial Growth and Clinical Adoption - Yahoo Finance
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SeaStar - TMX Newsfile
Form 4 SeaStar Medical Holding Corp For: 2 July By Investing.com - Investing.com Canada
SeaStar Medical (ICU) CEO receives 10,288 restricted stock units in equity grant - Stock Titan
SeaStar Medical (ICU) grants CMO 7,202 restricted stock units - Stock Titan
4,000-share RSU grant to SeaStar Medical (ICU) director disclosed - Stock Titan
SeaStar Medical (ICU) director awarded 4,000 RSUs, holdings now 16,200 shares - Stock Titan
SeaStar Medical (ICU) director granted 4,000 restricted stock units - Stock Titan
SeaStar Medical (NASDAQ: ICU) director receives 4,000 restricted stock units - Stock Titan
SeaStar Medical Q1 2026 Earnings: EPS Misses Estimates as Company Advances DevelopmentGuidance vs Actual - dars.gov.et
SeaStar Medical (ICU) adopts 2026 retention bonus program for top executives - Stock Titan
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Q2 Virtual Investor Summit Presentations Now Available On Demand - Moomoo
ICU Q1 2026 Earnings: Narrowing Operating Losses Amid Strategic ProgressEarnings Surprise Report - DonanımHaber
ICU News | SEASTAR MEDICAL HOLDING CORP (NASDAQ:ICU) - ChartMill
SeaStar Medical (NASDAQ: ICU) amends Mr. Green separation deal - Stock Titan
Seastar Medical Announces New Icd-10-Pcs Codes for Its Scd Therapy for Acute Kidney Injury - marketscreener.com
Seastar Medical Holding Corp Azioni (ICU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Seastar Medical Holding Corp Azioni (ICU) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Baird Jennifer A | Director |
Dec 19 '25 |
Buy |
0.24 |
4,200 |
987 |
36,200 |
| Messinger Michael | Chief Financial Officer |
Dec 09 '25 |
Buy |
0.35 |
14,500 |
5,098 |
17,500 |
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):